{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:27:20Z","timestamp":1785407240806,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022416","name":"Center for Drug Evaluation and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xphs.2026.104215","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:13:20Z","timestamp":1771431200000},"page":"104215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Determination of naloxone and its impurities in a vaporized matrix by LC-MS\/MS: Application of an in vitro surrogate model platform to assess in vivo permeation and risk associated with vaping opioids"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6794-0409","authenticated-orcid":false,"given":"Dustin G.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasmin Ara","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7719-0813","authenticated-orcid":false,"given":"Patrick","family":"Faustino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3649-0449","authenticated-orcid":false,"given":"Diaa","family":"Shakleya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"39","key":"10.1016\/j.xphs.2026.104215_bib0001","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.15585\/mmwr.mm7039a4","article-title":"Notes from the field: E-cigarette use among middle and high school students - national youth tobacco survey, United States, 2021","volume":"70","author":"Park-Lee","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.xphs.2026.104215_bib0002","unstructured":"FDA. Results from the Annual National Youth Tobacco Survey. Available at:https:\/\/www.fda.gov\/tobacco-products\/youth-and-tobacco\/results-annual-national-youth-tobacco-survey#2022%20Findings."},{"issue":"1","key":"10.1016\/j.xphs.2026.104215_bib0003","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1186\/s12889-020-09572-x","article-title":"E-cigarettes use in the United States: reasons for use, perceptions, and effects on health","volume":"20","author":"Sapru","year":"2020","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.xphs.2026.104215_bib0004","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4155","article-title":"Exposure to advertisements and electronic cigarette use among us middle and high school students","volume":"137","author":"Singh","year":"2016","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.xphs.2026.104215_bib0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jadohealth.2016.06.013","article-title":"Exposure to advertisements and susceptibility to electronic cigarette use among youth","volume":"59","author":"Dai","year":"2016","journal-title":"J Adolesc Health"},{"issue":"1","key":"10.1016\/j.xphs.2026.104215_bib0006","first-page":"56","article-title":"The vaping epidemic in adolescents","volume":"117","author":"Jones","year":"2020","journal-title":"Mo Med"},{"key":"10.1016\/j.xphs.2026.104215_bib0007","series-title":"U.S. Surgeon General's Report on E-Cigarette Use Among Youth and Young Adults","author":"General","year":"2016"},{"issue":"8","key":"10.1016\/j.xphs.2026.104215_bib0008","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ntr\/ntx231","article-title":"Associations between early onset of E-cigarette use and cigarette smoking and other substance use among US adolescents: a national study","volume":"20","author":"McCabe","year":"2018","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"10.1016\/j.xphs.2026.104215_bib0009","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/add.15246","article-title":"Gateway or common liability? A systematic review and meta-analysis of studies of adolescent e-cigarette use and future smoking initiation","volume":"116","author":"Chan","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.xphs.2026.104215_bib0010","unstructured":"FDA and CBP Seize Nearly $34 Million Worth of Illegal E-Cigarettes During Joint Operation. https:\/\/www.fda.gov\/; 2025."},{"issue":"43","key":"10.1016\/j.xphs.2026.104215_bib0011","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2014United States, 1999\u20132008","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.xphs.2026.104215_bib0012","unstructured":"CDC. Opioid Data Analysis and Resources. Available at: https:\/\/www.cdc.gov\/opioids\/data\/analysis-resources.html."},{"key":"10.1016\/j.xphs.2026.104215_bib0013","unstructured":"Understanding the Opioid Overdose Epidemic. Available at: https:\/\/www.cdc.gov\/overdose-prevention\/about\/understanding-the-opioid-overdose-epidemic.html."},{"key":"10.1016\/j.xphs.2026.104215_bib0014","unstructured":"[dataset] Wide-ranging online data for epidemiologic research (WONDER), 2021. http:\/\/wonder.cdc.gov."},{"issue":"8","key":"10.1016\/j.xphs.2026.104215_bib0015","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1177\/08901171231193785","article-title":"Vaping opioids: should we be worried?","volume":"37","author":"Morris","year":"2023","journal-title":"Am J Health Promot"},{"issue":"5","key":"10.1016\/j.xphs.2026.104215_bib0016","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1213\/ANE.0000000000002403","article-title":"The US Opioid Crisis: current federal and state legal issues","volume":"125","author":"Soelberg","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.xphs.2026.104215_bib0017","series-title":"Tackling the Opioid Crisis Requires a Whole-of-Government, Society-Wide Approach","author":"Truong","year":"2023"},{"issue":"2","key":"10.1016\/j.xphs.2026.104215_bib0018","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0033354916688206","article-title":"How states are tackling the opioid crisis","volume":"132","author":"Wickramatilake","year":"2017","journal-title":"Public Health Rep"},{"issue":"1","key":"10.1016\/j.xphs.2026.104215_bib0019","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41398-020-0847-1","article-title":"America's opioid crisis: the need for an integrated public health approach","volume":"10","author":"Blanco","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.xphs.2026.104215_bib0020","series-title":"Community Engagement: An Essential Component of an Effective and Equitable Substance Use Prevention System","year":"2022"},{"key":"10.1016\/j.xphs.2026.104215_bib0021","unstructured":"CDC. Understanding the opioid overdose epidemic. Available at:https:\/\/www.cdc.gov\/overdose-prevention\/about\/understanding-the-opioid-overdose-epidemic.html."},{"issue":"12","key":"10.1016\/j.xphs.2026.104215_bib0022","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/thoraxjnl-2015-208039","article-title":"Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner","volume":"71","author":"Garcia-Arcos","year":"2016","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.xphs.2026.104215_bib0023","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40262-024-01355-6","article-title":"Clinical pharmacokinetics and pharmacodynamics of naloxone","volume":"63","author":"Saari","year":"2024","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.xphs.2026.104215_bib0024","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/2042098614564776","article-title":"Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access","volume":"6","author":"Wermeling","year":"2015","journal-title":"Ther Adv Drug Saf"},{"issue":"8","key":"10.1016\/j.xphs.2026.104215_bib0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jat\/33.8.409","article-title":"Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization- tandem mass spectrometry","volume":"33","author":"Fang","year":"2009","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.xphs.2026.104215_bib0026","series-title":"Bioanalytical method validation guidance for industry","year":"2018"},{"key":"10.1016\/j.xphs.2026.104215_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107837","article-title":"The chemistry and toxicology of vaping","volume":"225","author":"Bonner","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.xphs.2026.104215_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2025.111739","article-title":"Toxicity of humectants propylene glycol and vegetable glycerin in electronic nicotine delivery systems","volume":"413","author":"Sun","year":"2025","journal-title":"Toxicol Lett"},{"issue":"6","key":"10.1016\/j.xphs.2026.104215_bib0029","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/jat\/bkw037","article-title":"Concentration of nicotine and glycols in 27 electronic cigarette formulations","volume":"40","author":"Peace","year":"2016","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.xphs.2026.104215_bib0030","series-title":"<621>Chromatography","year":"2017"},{"issue":"1","key":"10.1016\/j.xphs.2026.104215_bib0031","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/s12889-017-4533-z","article-title":"Mining online e-liquid reviews for opinion polarities about e-liquid features","volume":"17","author":"Chen","year":"2017","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.xphs.2026.104215_bib0032","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1038\/s41598-024-52317-8","article-title":"The combination of propylene glycol and vegetable glycerin e-cigarette aerosols induces airway inflammation and mucus hyperconcentration","volume":"14","author":"Kim","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2026.104215_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1012723","article-title":"Vegetable glycerin e-cigarette aerosols cause airway inflammation and ion channel dysfunction","volume":"13","author":"Kim","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492600064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492600064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:08:51Z","timestamp":1777442931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235492600064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S002235492600064X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104215","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of naloxone and its impurities in a vaporized matrix by LC-MS\/MS: Application of an in vitro surrogate model platform to assess in vivo permeation and risk associated with vaping opioids","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104215"}}